First Trust NYSE Arca Biotechnology Index Fund
112 hedge funds and large institutions have $292M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 48 reducing their positions, and 8 closing their positions.
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
61% more call options, than puts
Call options by funds: $3.62M | Put options by funds: $2.24M
6% more capital invested
Capital invested by funds: $275M → $292M (+$17.1M)
5% more funds holding
Funds holding: 107 → 112 (+5)
0.01% more ownership
Funds ownership: 33.81% → 33.82% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
44% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 48
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$4.94M |
| 2 |
NA
Navellier & Associates
Reno,
Nevada
|
+$4.46M |
| 3 |
Morgan Stanley
New York
|
+$4.28M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.29M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$1.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$5.65M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.23M |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$2.81M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.32M |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$1.74M |
FBT Hedge Fund Activity: Q3 2016 in Review
112 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2016, worth a combined $292M — up 6.2% from $275M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new FBT positions and 8 closed out — a net gain of 7 holders — while 27 added to existing stakes and 48 trimmed.
The largest buyer was Wells Fargo, adding an estimated $4.94M. The largest seller was SG Americas Securities, cutting an estimated $5.65M.
- 112 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2016, up from 107 in Q2 2016.
- Funds reported $292M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2016, up 6.2% quarter-over-quarter.
- 15 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2016 and 8 closed out, a net change of +7 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2016 was Wells Fargo, an estimated $4.94M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2016 was SG Americas Securities, an estimated $5.65M sold.
Based on aggregated 13F filings for Q3 2016.